Literature DB >> 12840860

A rapid screening and diagnosis on fragile X syndrome by PCR.

J Chen1, A Yang, H Fei, R Jin, M He, B Wang.   

Abstract

Polymerase chain reaction (PCR) technique combined with direct detection by silver staining on denaturing DNA sequencing gel was used to analyze the (CGG)n repeats within the FMR1 gene on 169 suspected patients with mental retardation and 33 kindreds of 6 fragile X families. The results showed that: (1) No PCR products were detected in 3 males in the suspected group. (2) In the fragile X family studies, the 5 male probands failed to show any PCR products. (3) Diplex PCR with the primers flanking the FRAXE locus was used to serve as an internal control for the 8 above-mentioned males and only normal products of the FRAXE locus were detected, indicating that the possibility of false negative results of the FRAXA locus could be eliminated. These findings suggested that analysis of (CGG)n repeat within the FMR1 gene by PCR technique could efficiently detect premutation carriers and that negative PCR products in mentally retarded males might highly imply the diagnosis of fragile X syndrome after the false negative results have been excluded by diplex PCR. This PCR assay is suitable for the screening and diagnosis of fragile X syndrome in a large number of populations due to its rapidity, simplicity, stability and reliability.

Entities:  

Mesh:

Year:  1999        PMID: 12840860     DOI: 10.1007/bf02886897

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

1.  Standards for selected anthropometric measurements in males with the fragile X syndrome.

Authors:  M G Butler; A Brunschwig; L K Miller; R J Hagerman
Journal:  Pediatrics       Date:  1992-06       Impact factor: 7.124

2.  Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture.

Authors:  G R Sutherland
Journal:  Am J Hum Genet       Date:  1979-03       Impact factor: 11.025

3.  Identification of the FRAXE fragile site in two families ascertained for X linked mental retardation.

Authors:  G A Flynn; M C Hirst; S J Knight; J N Macpherson; J C Barber; A V Flannery; K E Davies; V J Buckle
Journal:  J Med Genet       Date:  1993-02       Impact factor: 6.318

4.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

5.  Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.

Authors:  A K Taylor; J F Safanda; M Z Fall; C Quince; K A Lang; C E Hull; I Carpenter; L W Staley; R J Hagerman
Journal:  JAMA       Date:  1994-02-16       Impact factor: 56.272

6.  Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation.

Authors:  S J Knight; A V Flannery; M C Hirst; L Campbell; Z Christodoulou; S R Phelps; J Pointon; H R Middleton-Price; A Barnicoat; M E Pembrey
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

7.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

8.  Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.

Authors:  W T Brown; G E Houck; A Jeziorowska; F N Levinson; X Ding; C Dobkin; N Zhong; J Henderson; S S Brooks; E C Jenkins
Journal:  JAMA       Date:  1993-10-06       Impact factor: 56.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.